In a groundbreaking shift in our understanding of mutations, researchers have discovered types of DNA damage in healthy cells ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

While some mutations in the BRCA2 gene clearly indicate risks for breast and prostate cancer, thousands of less-common ...

Some DNA damage evades repair for years, causing repeated mutations during cell division, increasing cancer risk, especially ...

Researchers at the University of Florida College of Veterinary Medicine and the UF Health Cancer Center have identified a ...

Molecular oncology is revolutionizing cancer care by using genetic profiling to tailor personalized treatments, improving ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

A study released by the National Cancer Center Japan has revealed higher rates of mutations in a tumor-suppressing gene, TP53, in Japanese cancer patients compared to those in the United States.

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

A recent study that focused on women under 55 years old found an increase in pancreatic cancer cases.Mercy Medical Center Dr.